F. Carsten Thiel
Chief Executive Officer at EUSA Pharma (UK) Ltd.
Profile
F.
Carsten Thiel is currently the Chief Executive Officer & Director at EUSA Pharma (UK) Ltd.
He was previously the Chief Executive Officer & Director at Abeona Therapeutics, Inc. for a brief period in 2018.
He also served as the Chief Executive Officer at AMGEN GmbH and as a Director at Karyopharm Therapeutics, Inc. He was the Vice President & Head-Europe at Amgen, Inc. from 2011 to 2014 and the Executive VP & Chief Commercial Officer at Alexion Pharmaceuticals, Inc. from 2014 to 2017.
Dr. Thiel holds a doctorate degree from Max-Planck-Institute for Molecular Genetics and a graduate degree from Philipps University of Marburg.
F. Carsten Thiel active positions
| Companies | Position | Start |
|---|---|---|
EUSA Pharma (UK) Ltd.
 EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services EUSA Pharma (UK) Ltd. supplies medicines and medical devices. It offers Caphosol, Xenazine, Collatamp, Custodiol, and Fomepizole. The company was founded in March 2015 and is headquartered in Hemel Hempstead, the United Kingdom. | Chief Executive Officer | 2021-03-30 |
Former positions of F. Carsten Thiel
| Companies | Position | End |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Director/Board Member | 2018-11-26 |
| ABEONA THERAPEUTICS INC. | Chief Executive Officer | 2018-11-25 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2017-05-31 |
| AMGEN INC. | Corporate Officer/Principal | 2013-12-31 |
AMGEN GmbH
 AMGEN GmbH BiotechnologyHealth Technology AMGEN GmbH develops, manufactures, and markets human therapeutics based on cellular biology. It was established to help sell and distribute biotechnical therapies for the treatment of such ailments as chemotherapy side effects, chronic kidney failure, and rheumatoid arthritis. Among the group's products are Epogen & Aranesp for the treatment of anemia in people with chronic kidney disease; Neupogen & Neulasta to help restore white blood cell counts for cancer patients and Enbrel for the treatment of psoriasis and rheumatoid arthritis. The company was founded in 1980 and is headquartered in Munich, Germany. | Chief Executive Officer | - |
Training of F. Carsten Thiel
| Max-Planck-Institute for Molecular Genetics | Doctorate Degree |
| Philipps University of Marburg | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| ABEONA THERAPEUTICS INC. | Health Technology |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| Private companies | 3 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
AMGEN GmbH
AMGEN GmbH BiotechnologyHealth Technology AMGEN GmbH develops, manufactures, and markets human therapeutics based on cellular biology. It was established to help sell and distribute biotechnical therapies for the treatment of such ailments as chemotherapy side effects, chronic kidney failure, and rheumatoid arthritis. Among the group's products are Epogen & Aranesp for the treatment of anemia in people with chronic kidney disease; Neupogen & Neulasta to help restore white blood cell counts for cancer patients and Enbrel for the treatment of psoriasis and rheumatoid arthritis. The company was founded in 1980 and is headquartered in Munich, Germany. | Health Technology |
EUSA Pharma (UK) Ltd.
EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services EUSA Pharma (UK) Ltd. supplies medicines and medical devices. It offers Caphosol, Xenazine, Collatamp, Custodiol, and Fomepizole. The company was founded in March 2015 and is headquartered in Hemel Hempstead, the United Kingdom. | Distribution Services |
- Stock Market
- Insiders
- F. Carsten Thiel
